Jane Street’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.9K Buy
+10,500
New +$110K ﹤0.01% 10761
2023
Q4
Sell
-227,400
Closed -$2.8M 9601
2023
Q3
$2.8M Buy
+227,400
New +$3.38M ﹤0.01% 3482
2023
Q2
Sell
-52,900
Closed -$921K 9266
2023
Q1
$921K Sell
52,900
-9,600
-15% -$137K ﹤0.01% 5149
2022
Q4
$578K Buy
62,500
+24,000
+62% +$224K ﹤0.01% 5874
2022
Q3
$331K Buy
+38,500
New +$382K ﹤0.01% 7419
2022
Q2
Sell
-47,500
Closed -$577K 10463
2022
Q1
$577K Buy
47,500
+18,100
+62% +$381K ﹤0.01% 7194
2021
Q4
$1M Buy
29,400
+12,400
+73% +$486K ﹤0.01% 5884
2021
Q3
$820K Buy
17,000
+1,300
+8% +$60.2K ﹤0.01% 6314
2021
Q2
$709K Buy
15,700
+1,500
+11% +$66.5K ﹤0.01% 6569
2021
Q1
$685K Buy
14,200
+5,100
+56% +$266K ﹤0.01% 6211
2020
Q4
$490K Buy
9,100
+2,000
+28% +$90.4K ﹤0.01% 5776
2020
Q3
$262K Sell
7,100
-6,800
-49% -$253K ﹤0.01% 6073
2020
Q2
$431K Buy
+13,900
New +$385K ﹤0.01% 5299

Other funds holding NEO

Jane Street's NEO Position: Q1 2026 in Review

Jane Street sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 114,016 shares — an estimated $1.2M sold.

Jane Street first reported a position in NEO in Q4 2018 and held it in 22 quarters. The position peaked at $4.83M in Q2 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Jane Street reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 114,016 NeoGenomics shares in Q1 2026, an estimated $1.2M.
  • Jane Street first reported a position in NeoGenomics in Q4 2018 and held it in 22 quarters.
  • Jane Street's NeoGenomics position peaked at $4.83M in Q2 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.